ライフサイエンスコーパス: serum testosterone

1 ercent and 83 percent for the measurement of serum testosterone.

2 vity risk for each 1-ng/mL increase in total serum testosterone.

3 one to achieve physiologic concentrations of serum testosterone.

4 Prednisone was the major predictor of serum testosterone.

5 ing VEGF164 expression with little change of serum testosterone.

6 ation, with elevated serum estradiol and low serum testosterone.

7 ion between risk of cognitive impairment and serum testosterone.

8 In select cases, measurement of serum testosterone and assessment of sperm DNA integrity

9 here were weak negative correlations between serum testosterone and bone density (-0.20 < r < -0.28;

10 se effect of CsA and no relationship between serum testosterone and bone density change were detected

11 Serum testosterone and DHEA-S levels were not statistica

12 DEHP-induced elevations in serum testosterone and E2 levels suggest the possibility

13 ring at P63 showed significant reductions in serum testosterone and epididymal sperm count.

14 when given in dosages of 300 mg/d, increases serum testosterone and estradiol concentrations in some

15 Serum testosterone and estradiol levels were assayed.

16 Baseline serum testosterone and estradiol were measured by radioi

17 t of a single 100-mg androstenedione dose on serum testosterone and estrogen concentrations was deter

18 Blood samples were obtained to measure total serum testosterone and perform the FibroSURE-ActiTest.

19 In contrast, L-2 enhanced serum testosterone and prostatic DHT concentrations by >

20 reater body weight was associated with lower serum testosterone and SHBG, and greater E2.

21 onstrated the greatest percentage decline in serum testosterone, androsterone, and dehydroepiandroste

22 An increase of 6 nmol/L serum testosterone ( approximately 1 SD) was associated

23 behavior in rats in response to the surge in serum testosterone at approximately birth.

24 production over the grafting period, whilst serum testosterone at termination was unchanged.

25 e grafting period, and single measurement of serum testosterone at termination.

26 d Leydig cell hypoplasia and lower levels of serum testosterone, but it is not clear whether this is

27 ual dysfunction has not been associated with serum testosterone, but this may be confounded by limita

28 ed a mean increase of 271 ng/dl in the nadir serum testosterone concentration (to the middle of the n

29 zman rats were used to observe the course of serum testosterone concentration following orchiectomy (

30 gned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per

31 ular volumes (18+/-5 vs. 3+/-2 ml, P<0.001), serum testosterone concentrations (78+/-34 vs. 49+/-20 n

32 oxically, rapid cycling between high and low serum testosterone concentrations (bipolar androgen ther

33 men with prostate cancer, PC-SPES decreased serum testosterone concentrations (P<0.05), and in eight

34 S-AR(-/y) mice also have lower serum testosterone concentrations and higher serum leute

35 Serum testosterone concentrations and urinary bisphenol

36 Their testes are 80% smaller and serum testosterone concentrations are lower than in wild

37 ndicate that, within the normal range, lower serum testosterone concentrations are not associated wit

38 PM-AR-/y mice have serum testosterone concentrations comparable with AR+/y

39 Serum testosterone concentrations decrease as men age, b

40 f the first studies to examine correlates of serum testosterone concentrations in anticipation of the

41 f testosterone therapy is usually to achieve serum testosterone concentrations in the male reference

42 stenedione supplementation does not increase serum testosterone concentrations or enhance skeletal mu

43 that DHEA supplementation does not increase serum testosterone concentrations or increase strength i

44 hanges in the area under the curve (AUC) for serum testosterone concentrations were -2% (7%), -4% (4%

45 opathic infertility, sexual dysfunction, low serum testosterone concentrations, and apulsatile secret

46 induced AAAs in adult females exhibiting low serum testosterone concentrations.

47 lement had similar sex organ weights and low serum testosterone concentrations.

48 Serum testosterone, estradiol, sex hormone binding globu

49 Serum PSA had to be > or = 4 ng/mL and serum testosterone had to be in the noncastrate range.

50 Low pretransplant serum testosterone has recently been associated with inc

51 Low nadir serum testosterone (ie, < 0.7 mmol/L) within the first y

52 s (age at diagnosis, 2 days to 11 years) and serum testosterone in 54 of them either after the admini

53 their wild-type littermates with comparable serum testosterone in both male and female mice.

54 Low preliver transplant serum testosterone independently predicts a decreased ri

55 lyses and measurements of testicular volume, serum testosterone, inhibin B, and gonadotropins in thes

56 Total serum testosterone is associated with an increased risk

57 ty and prostate cancer include the impact on serum testosterone, leptin, insulin-like growth factor I

58 s, 788 men who were 65 years or older with a serum testosterone level less than 275 ng/mL and impaire

59 er, with limitations in mobility and a total serum testosterone level of 100 to 350 ng per deciliter

60 liter (3.5 to 12.1 nmol per liter) or a free serum testosterone level of less than 50 pg per millilit

61 underwent coronary angiography and had a low serum testosterone level, the use of testosterone therap

62 emission tomography-computed tomography, and serum testosterone levels > 50 ng/mL.

63 ative analysis revealed that despite similar serum testosterone levels among the groups, the volume o

64 Moreover, men with elevated serum testosterone levels and associated gene signatures

65 dual variability, and the connection between serum testosterone levels and clinical psychiatric signs

66 eover, high-fat feeding induces elevation of serum testosterone levels and enlargement of seminal ves

67 In alcohol-fed rats, serum testosterone levels and hepatic activity of 2 andr

68 re observed in the Six5+/- and Six5-/- mice, serum testosterone levels and intra-testicular inhibin a

69 rength and function correlated directly with serum testosterone levels and inversely with CAG repeat

70 regarding the effects of varicocelectomy on serum testosterone levels are limited and conflicting.

71 Medical castration based on serum testosterone levels cannot be equated with androge

72 As serum testosterone levels did not decline with age, loca

73 ecovery in parallel with peaks and nadirs in serum testosterone levels during intermittent testostero

74 tween alleles of this polymorphism and total serum testosterone levels in both affected and unaffecte

75 tor inhibition in vivo significantly reduced serum testosterone levels in male mice, demonstrating th

76 [22.2 nmol/L]) with no significant change in serum testosterone levels in matched, placebo-treated me

77 n the basis of prior hormone exposure and by serum testosterone levels into androgen-dependent and an

78 aged 65 years or older with an average of 2 serum testosterone levels lower than 275 ng/dL (82 men a

79 44 men, aged 44 to 78 years, with screening serum testosterone levels lower than 300 ng/dL (<10.4 nm

80 ance, defined as disease progression despite serum testosterone levels of <20 ng/dl.

81 Serum testosterone levels of untreated mice negatively c

82 Low serum testosterone levels still occur in the early postt

83 Testosterone replacement therapy increased serum testosterone levels to the mid-normal range (media

84 Testosterone treatment increased serum testosterone levels to the mid-normal range for me

85 Significantly lower serum testosterone levels were detected in both the low-

86 d a lower maximum growth velocity, and their serum testosterone levels were significantly lower compa

87 maturation (bone age), pubertal progression, serum testosterone levels, height velocity, and stature

88 incomplete germ cell development and lowered serum testosterone levels, which resulted in azoospermia

89 terature on the impact of varicocelectomy on serum testosterone levels.

90 assessed the impact of varicocele repair on serum testosterone levels.

91 0.05, 95% CI 0.01-0.19) after adjustment for serum testosterone levels.

92 f abiraterone, a CYP17 inhibitor that lowers serum testosterone (< 1 ng/dL) and improves survival in

93 s were highly and negatively associated with serum testosterone (males: r = -0.746 and females: r = -

94 inhibiting substance was more sensitive than serum testosterone measurement for the identification of

95 Men with either serum testosterone or IGF-1 levels in upper quartile of

96 ively associated with cotton wool spots, and serum testosterone response during flight was associated

97 at (1) alcohol induces profound reduction of serum testosterone, resulting in loss of androgen-regula

98 Pretransplantation serum testosterone, SHBG, and other variables were colle

99 o loci, SHBG at 17p13 and FAM9B at Xp22, for serum testosterone (T) levels; however, these explain on

100 Serum testosterone (T), 17 beta-estradiol (E2), and dihy

101 es of testosterone initiation without recent serum testosterone testing.

102 (1) Rates of new serum testosterone testing; (2) rates of testosterone in

103 90 (mean age, 49.6 [SD, 11.5] years) had new serum testosterone tests and 283317 (mean age, 51.8 [SD,

104 Serum testosterone was increased in epileptic rats, but

105 Serum testosterone was low in 24% of male multiple scler

106 Mean total serum testosterone was significantly higher in advanced

107 Serum testosterone was within physiological levels in th